Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDC42 intronic transcript 1 (CDC42-IT1) is a long non-coding RNA transcribed from the intronic region of the CDC42 gene locus. Unlike the protein-coding CDC42 gene, which encodes a small Rho-family GTPase involved in cell morphology, signaling, migration, and tumorigenesis, CDC42-IT1 does not encode a protein. It is classified as an lncRNA and its biological role is not fully characterized, though it has been reported in some research as possibly regulating gene expression or being implicated in tumor biology. However, there is little to no direct evidence that CDC42-IT1 itself is a validated therapeutic target or biomarker. Most research and therapeutic interest revolves around the CDC42 protein itself, not CDC42-IT1[5][2][3][4]. Key distinction: The major conflation in the literature is between CDC42-IT1 (a non-coding RNA with unclear function) and CDC42 (the well-studied small GTPase, a clear therapeutic and research target). CDC42 is involved in actin cytoskeletal organization, cell cycle, and cancer biology, while CDC42-IT1 is a non-coding gene product with potential, but unvalidated, roles in gene regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDC42 intronic transcript 1 (CDC42-IT1).